Cybin (HELP) Other Operating Expenses (2020 - 2026)
Cybin (HELP) posted quarterly Other Operating Expenses of $5.3 million for Q1 2026, down 82.39% year-on-year from $29.8 million in Q1 2025, and up 17.4% on a QoQ basis from $4.5 million in Q4 2025.
Cybin (HELP) Other Operating Expenses (2020 - 2026) Analysis & Trends
Cybin (HELP) has reported Other Operating Expenses for 7 consecutive years, with $5.3 million the latest figure, recorded in Q1 2026.
- Quarterly Other Operating Expenses fell 82.39% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.9 million (down 63.64% YoY) and the FY2026 annual result came in at $10.9 million, down 64.77% from the prior year.
- Other Operating Expenses grew to $5.3 million in Q1 2026 per HELP's latest filing, from $4.5 million in the prior quarter.
- Over the last five years, Other Operating Expenses for HELP reached as high as $29.8 million in Q1 2025 and fell as low as -$16.6 million in Q1 2023.
- A 5-year average of $2.4 million and a median of $200764.4 in 2024 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2022 — Other Operating Expenses plunged 135.3% — and 2025, when it surged 187036.78%.
- Year by year, Other Operating Expenses stood at -$21.0 in 2022, then surged by 34826.04% to $7292.5 in 2023, then sank by 67.19% to $2392.4 in 2024, then jumped by 187036.78% to $4.5 million in 2025, then increased by 17.4% to $5.3 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $5.3 million, $4.5 million, and $377000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.26 Mn |
| Dec 31, 2025 | 4.48 Mn |
| Sep 30, 2025 | 377,000.00 |
| Jun 30, 2025 | 753,000.00 |
| Mar 31, 2025 | 29.85 Mn |
| Dec 31, 2024 | 2,392.37 |
| Sep 30, 2024 | 24,528.70 |
| Jun 30, 2024 | 2,123.23 |
| Mar 31, 2024 | 10.30 Mn |
| Dec 31, 2023 | 7,292.47 |
| Sep 30, 2023 | 1,054.75 |
| Jun 30, 2023 | 949,176.89 |
| Feb 28, 2023 | -16.60 Mn |
| Sep 30, 2022 | -21.00 |
| May 31, 2022 | 2.80 Mn |
| Mar 31, 2022 | -1,436.00 |
| Dec 31, 2021 | -695.00 |
| Sep 30, 2021 | -506,038.73 |
| Jun 30, 2021 | -497.88 |
| Mar 31, 2021 | 4,068.00 |